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Obstetricians and gynecologists, urogynecologists, and
other health care providers caring for women with pelvic
floor dysfunction have classically focused on bladder and
bowel control problems and pelvic organ prolapse. The eva-
luation, treatment, and research aimed at understanding the
underlying pathophysiology of these conditions have cen-
tered on these 3 domains of pelvic floor function. However,
in the last 5 years, we have seen a fourth domain added, that
of sexual function [1].
Sexual function and female sexual dysfunction (FSD),
as related to other pelvic floor conditions, are of vital
importance for two major reasons. First, sexual function can
be greatly impacted by other pelvic conditions, such as
urinary incontinence or pelvic organ prolapse. Pelvic floor
disorders may lead to FSD, the disturbance in sexual desire
and psychophysiological changes that characterize the
sexual response and cause marked distress and personal
difficulty. The key to determining FSD is measuring the
distress and personal difficulty to sexual function. Lack of
sexual activity or desire may not cause distress for all
women. Yet fear of urinary incontinence with intercourse,
loss of self-esteem secondary to urine or bowel leakage, and
pain or discomfort secondary to vaginal prolapse can greatly
impact a woman's desire for sexual activity and comfort
during intercourse, and can lead to FSD [2]. Second,
treatments, including pharmacotherapy, pessaries, and
surgeries can impact sexual function and FSD in a positive
or negative way [3]. Clinicians caring for women with pelvic
floor dysfunction need to be aware of these interactions
when forming treatment plans and should discuss the
possible benefits and risks of different therapies on sexual
function.
Sexuality, sexual response, and sexual function are a re-
sult of complex psychological, social, neurological, andogy andObstetrics. PublishedbyElsevier IrelandLtd. All rights reserved.
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specific links to other disease processes, such as urinary
incontinence, are very challenging. The reported prevalence
of FSD in female populations worldwide ranges from 20% to
50% and in women with urinary incontinence the prevalence
of FSD is as high as 47%.
The two papers in this issue of the IJGO—one from France
by Berthier et al. [4] on “Sexual function in women following
the transvaginal tension-free tape procedure for inconti-
nence,” and one from the United Kingdom by Thaker et al.
[5] on “Sexual function following pelvic floor surgery”—focus
our attention on the impact surgical treatments may have on
sexual function. The articles are similar in that they aim to
detect change in sexual function following surgical interven-
tions and, as is common in this field of study, they differ in
the methods and questionnaires used to assess sexual func-
tion [6,7].
Berthier et al. [4] performed a retrospective chart review
to identify women who underwent a tension-free vaginal
tape (TVT) procedure for stress urinary incontinence. A
nonvalidated but often used questionnaire was sent via
postal service to 135 women. Sixty-six questionnaires were
reported on for an analyzable response rate of 50%. Mean
follow-up was 38 ± 15.5 months. Overall, 70% of the women
were not sexually active before and after surgery because of
lack of a partner. One woman who was not sexually active
before surgery because of urinary incontinence with inter-
course became sexually active after the procedure. Half of
the women reported no change in intercourse following the
surgery, 25% reported that intercourse was worse, and 25%
reported that intercourse was better. This study is consistent
with the literature, nicely reviewed in the paper, which is
equally split on the improvement or decline in sexual
function following TVT. For some women, decrease in the
fear of incontinence and rise is self-esteem and quality of life
with resolution of incontinence may result in an improve-
ment in sexual function. For other women, possibly due
to pain, proximity of the tape to clitoral branches of the
pudendal nerve, or erosion of the mesh tape, coital sexual
pleasure could decline. My take home message from this
paper, and in reviewing the other literature, is that we must
council women that a TVT or other midurethral sling may
positively or negatively impact sexual function. However, the
majority of women will see no impact. Talking with the
patient about her sexual activity, fears, orgasmic function,
and how she relates her incontinence to sexual function
before surgery is imperative.
Thacker et al. [5] performed a prospective study of 35
women undergoing prolapse and urinary incontinence sur-
geries who were queried before and 4 months after surgery.
The study used the validated short-form Pelvic Organ
Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ)
and found an overall improvement in sexual function with
statistical increases in the overall score and the physical- and
partner-related domains. In addition, the study evaluated
the reliability and performance of this questionnaire, de-
veloped in the United States, in a different culture and
population. The authors point out the importance of culturalnorms and language when discussing sexual practices. In
their population the question addressing masturbation was
not completed by a majority of women. In addition, there
was poor reliability found for the partner-related section. In
summary, while the women showed improvement in sexual
function as demonstrated by the change in preoperative and
postoperative scores, the degree of distress related to sexual
dysfunction and the factors that determined improvement
after surgery could not be determined.
These articles are excellent examples of the new and vital
work being done to evaluate the domain of sexual function
and the pelvic floor. It is hoped that this expanding body
of knowledge, using culturally specific validated question-
naires, will answer many questions concerning relationships
between anatomy and function of the pelvic floor and sexual
function. In addition, an increasing concern is the rise in
permanent mesh materials being used for surgical manage-
ment of urinary incontinence and pelvic organ prolapse, and
the impact the mesh will have on sexual function must be
explored [8]. Clinicians, surgeons, product manufacturers,
and patients must be diligent and thoughtful in evaluating
and reporting the benefits and risks of new and old
treatments for pelvic floor disorders on sexual function and
sexual health.
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